Cancer therapies dominate 40% of the global clinical pipeline, and the field of oncology is leading the precision medicine revolution.
Ingesting, integrating, standardizing, cleaning, coding, and analyzing disparate data sources creates complexity.
Discoveries driven by genomic data could dramatically increase the number of biomarkers available for use in clinical trials.
The world's oncology pipeline is rapidly growing, with nearly 40% of the global clinical pipeline focused on immuno-oncology.
Nearly 20 years ago Medidata was built around modernizing data capture and management, which ultimately became Rave. Today, we can confidently say we’re so much more than that.